Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,223 | 7,185 | 5,455 | 2,721 | 1,424 |
| Receivables | 919 | 2,190 | 641 | 610 | 750 |
| Other current assets | 3,990 | 4,755 | 1,069 | 0 | 0 |
| TOTAL | $9,110 | $14,872 | $7,918 | $4,229 | $2,798 |
| Non-Current Assets | |||||
| PPE Net | 3,915 | 3,400 | 3,237 | 3,783 | 4,255 |
| Intangibles | 988 | 1,213 | 1,339 | 1,844 | 2,081 |
| Other Non-Current Assets | 2,395 | 2,783 | 2,963 | 2,800 | 2,513 |
| TOTAL | $7,298 | $7,396 | $7,539 | $8,427 | $8,849 |
| Total Assets | $16,408 | $22,268 | $15,457 | $12,656 | $11,647 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,072 | 2,176 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 211 | 617 | 553 | 549 | 528 |
| Accrued Expenses | 1,694 | 1,718 | 1,307 | 1,136 | 1,558 |
| Other current liabilities | 639 | 481 | 237 | 367 | 192 |
| TOTAL | $5,122 | $7,093 | $3,608 | $3,388 | $3,868 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,366 | 3,143 | 962 | 29 | N/A |
| Deferred Revenues | 1,214 | 1,836 | 593 | 919 | 463 |
| Other Non-Current Liabilities | 0 | 7 | 0 | 141 | 323 |
| TOTAL | $7,438 | $4,251 | $2,647 | $1,374 | $1,429 |
| Total Liabilities | $12,560 | $11,344 | $6,255 | $4,762 | $5,297 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 92,439 | 92,381 | 78,723 | 71,516 | 70,998 |
| Common Shares | 9 | 462 | 393 | 355 | 305 |
| Retained earnings | -125,087 | -117,845 | -112,799 | -111,730 | -110,719 |
| Other shareholders' equity | -283 | 24 | 176 | 313 | 267 |
| TOTAL | $3,848 | $10,924 | $9,202 | $7,894 | $6,350 |
| Total Liabilities And Equity | $16,408 | $22,268 | $15,457 | $12,656 | $11,647 |